Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Blue Bird Corp (NQ: BLBD )

36.29 +2.31 (+6.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 326,984
Open 34.46
Bid (Size) 35.20 (1)
Ask (Size) 38.34 (1)
Prev. Close 33.98
Today's Range 34.22 - 36.54
52wk Range 17.43 - 39.01
Shares Outstanding 27,204,435
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Blue Bird Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Should you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?
Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD). 
Via Chartmill

Performance

YTD
+37.93%
+37.93%
1 Month
+0.72%
+0.72%
3 Month
+34.41%
+34.41%
6 Month
+91.71%
+91.71%
1 Year
+97.44%
+97.44%

More News

Read More
Looking for growth without the hefty price tag? Consider NASDAQ:BLBD.
Via Chartmill
Ahead of the Curve: 7 Stocks to Buy Before They Go Mainstream
Via InvestorPlace
Despite its impressive fundamentals, NASDAQ:BLBD remains undervalued.
Via Chartmill
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Topics Energy
Exposures Fossil Fuels
Is NASDAQ:BLBD suited for growth investing?
Via Chartmill
NASDAQ:BLBD, a growth stock which is not overvalued.
Via Chartmill
Is NASDAQ:BLBD a Fit for Growth Investing Strategies?
Via Chartmill
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning
Via Investor Brand Network
Topics Energy
Exposures Fossil Fuels
7 EV Stocks That Could Be Multibaggers in the Making: March Edition
Via InvestorPlace
3 Promising Small-Cap Stocks Packing a Powerful Punch
Via InvestorPlace
Beat Wall Street: 3 Stocks Flying Under the Radar
Via InvestorPlace
NASDAQ:BLBD is not too expensive for the growth it is showing.
Via Chartmill
What 4 Analyst Ratings Have To Say About Blue Bird
Via Benzinga
Should you consider NASDAQ:BLBD for growth investing?
Via Chartmill
Blue Bird Corp. (NASDAQ: BLBD) Sets New 52-Week High in Friday Session
Via Investor Brand Network
Topics Energy
Exposures Fossil Fuels
7 Must-Buy Stocks for a Diversified High-Growth Portfolio
Via InvestorPlace
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Via Newsfile
Is CRISPR Therapeutics the NVIDIA of gene editing?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Wall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
3 Goliath Growth Stocks Poised for Takeoff in February
Via InvestorPlace
Blue Bird Announces Launch of Secondary Public Offering
From Blue Bird Corporation
Via Business Wire
Gene therapy: Why does it cost millions for a single treatment?
Via MarketBeat
Exposures Product Safety
Win-Win Situation? Nuvve's (NASDAQ: NVVE) Technology Can Potentially Turn Your Electric Vehicle Into A Revenue Stream That Helps Support The Power Grid
Via Benzinga
Topics Electric Vehicles Emissions
Exposures Electric Vehicles
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.